Vodafone, Exco InTouch partner to develop patient reported outcomes solution

Wednesday, June 27, 2012 02:45 PM

Vodafone, a mobile communications company, has signed an agreement with Exco InTouch, a provider of compliant, interactive mobile patient management solutions, to deliver Vodafone Patient Reported Outcomes (Vodafone PRO), a solution that has the potential to improve patient compliance and data quality in clinical research.

Vodafone PRO enables high quality data to be gathered as trial participants report their experiences quickly and easily using their own mobile phone. The service will be available on a global scale, benefiting from Vodafone’s international footprint and in-depth mobile and consumer insight, along with Exco InTouch’s extensive background in patient engagement.

Vodafone selected Exco InTouch because the company provides simple, non-intrusive and compliant channels of communication. This enables sponsors and CROs to find and retain the right patients through engaging interactions and improved patient experience as well as offering customizable solutions to facilitate the collection of high quality patient data.

“With this collaboration, Vodafone is confident that we can offer our clients the most innovative and effective clinical research solutions available in the global market,” said Axel Nemetz, head of mHealth Solutions for Vodafone. “Our involvement will enable sponsors to choose our services for entire therapeutic areas around the world.”

Tim Davis, CEO of Exco InTouch, said that the partnership “demonstrates the extent to which mobile phone technology is increasingly being recognized by large pharmaceutical companies as an effective tool for the collection of clinical trial data. As a result of the partnership, research sponsors will be able to monitor safety and manage compliance in real time. This will make clinical trials easier and safer for patients, while enabling researchers to collect and process data quickly, accurately and reliably.”

Vodafone PRO can be configured for different study protocols in all phases of clinical research to collect crucial patient reported end point data. This scalable solution allows large volumes of high quality patient data to be securely transferred, validated and analysed in clinical trials. Vodafone PRO will make it easier for sponsors to retain and track people participating in trials and, through the patient-centered approach, is designed to improve the quality of data captured.

Share:          
CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs